Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Argos Nears Phase III Results For Precision Cancer Immunotherapy

Dec 10 2016

• By Joseph Haas

T-cell

Related Content

Novartis Tests Global Manufacturing Process For CAR-T Therapy

Sep 27 2016

Novartis, Kite Neck-And-Neck In CAR-T Race; Deaths Keep Juno In Third Place

Dec 05 2016

Argos Aims To Automate Cell-Based Cancer Therapy

Nov 20 2014

Related Companies

Argos Therapeutics, Inc.

Additional Topics

Clinical Trials ImmunoOncology Personalized Medicine Research & Development Cancer BioPharmaceutical

More from Anticancer

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window